Affiliation:
1. From the Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD
Abstract
Lung cancer is the leading cause of cancer death in the world today and is poised to claim approximately 1 billion lives during the 21st century. A major challenge in treating this and other cancers is the intrinsic resistance to conventional therapies demonstrated by the stem/progenitor cell that is responsible for the sustained growth, survival, and invasion of the tumor. Identifying these stem cells in lung cancer and defining the biologic processes necessary for their existence is paramount in developing new clinical approaches with the goal of preventing disease recurrence. This review summarizes our understanding of the cellular and molecular mechanisms operating within the putative cancer-initiating cell at the core of lung neoplasia.
Publisher
American Society of Clinical Oncology (ASCO)
Reference80 articles.
1. Global Cancer Statistics, 2002
2. Smoking and Carcinoma of the Lung
3. Peto R, Lopez, AD, Boreham J, et al: Mortality From Smoking in Developed Countries 1950-2000: Indirect Estimates From National Vital Statistics. New York, NY, Oxford University Press, 1994
4. Cancer Statistics, 2006
5. Changing Epidemiology of Small-Cell Lung Cancer in the United States Over the Last 30 Years: Analysis of the Surveillance, Epidemiologic, and End Results Database
Cited by
94 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献